Singapore markets closed

Sinopharm Tech Holdings Limited (8156.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.100+0.007 (+7.53%)
At close: 01:19PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 18.37M
Enterprise value 19.86M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.39
Price/book (mrq)32.67
Enterprise value/revenue 0.43
Enterprise value/EBITDA -0.87

Trading information

Stock price history

Beta (5Y monthly) 1.26
52-week change 3-79.33%
S&P500 52-week change 321.08%
52-week high 30.500
52-week low 30.089
50-day moving average 30.118
200-day moving average 30.149

Share statistics

Avg vol (3-month) 358.79k
Avg vol (10-day) 342.9k
Shares outstanding 5183.69M
Implied shares outstanding 6183.69M
Float 8116.32M
% held by insiders 133.37%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 329 Aug 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -61.98%
Operating margin (ttm)2.51%

Management effectiveness

Return on assets (ttm)-108.25%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)46.66M
Revenue per share (ttm)0.25
Quarterly revenue growth (yoy)58.00%
Gross profit (ttm)N/A
EBITDA -86.29M
Net income avi to common (ttm)-28.92M
Diluted EPS (ttm)-0.160
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.51M
Total cash per share (mrq)0.05
Total debt (mrq)10M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.16
Book value per share (mrq)-0.96

Cash flow statement

Operating cash flow (ttm)-1.3M
Levered free cash flow (ttm)-4.79M